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ABSTRACT 
HAGOBIAN, T. A., K. A. JACOBS, A. W. SUBUDHI, J. A. FATTOR, P. B. ROCK, S. R. MUZA, C. S. FULCO, B. BRAUN, A. 
GREDIAGIN, R. S. MAZZEO, A. CYMERMAN, and A. L. FRIEDLANDER. Cytokine Responses at High Altitude: Effects of 
Exercise and Antioxidants at 4300 m. Med. Sci. Sports Exerc., Vol. 38, No. 2, pp. 276–285, 2006. Purpose: This study tested 
the hypothesis that antioxidant supplementation would attenuate plasma cytokine (IL-6, tumor necrosis factor (TNF)-!), and C-
reactive protein (CRP) concentrations at rest and in response to exercise at 4300-m elevation. Methods: A total of 17 recreationally 
trained men were matched and assigned to an antioxidant (N = 9) or placebo (N = 8) group in a double-blinded fashion. At sea level 
(SL), energy expenditure was controlled and subjects were weight stable. Then, 3 wk before and throughout high altitude (HA), an 
antioxidant supplement (10,000 IU "-carotene, 200 IU !-tocopherol acetate, 250 mg ascorbic acid, 50 2g selenium, 15 mg zinc) or 
placebo was given twice daily. At HA, energy expenditure increased approximately 750 kcalIdj1 and energy intake decreased 
j1 j1approximately 550 kcalId , resulting in a caloric deficit of approximately 1200–1500 kcalId . At SL and HA day 1 (HA1) and day 
HA13, subjects exercised at 55% of V˙ O2peak until they expended approximately 1500 kcal. Blood samples were taken at rest, end of 
exercise, and 2, 4, and 20 h after exercise. Results: No differences were seen between groups in plasma IL-6, CRP, or TNF-! at rest or 
in response to exercise. For both groups, plasma IL-6 concentration was significantly higher at the end of exercise, 2, 4, and 20 h after 
exercise at HA1 compared with SL and HA13. Plasma CRP concentration was significantly elevated 20 h postexercise for both groups 
on HA1 compared to SL and HA13. TNF-! did not differ at rest or in response to exercise. Conclusion: Plasma IL-6 and CRP 
concentrations were elevated following exercise at high altitude on day 1, and antioxidant supplementation did not attenuate the rise in 
plasma IL-6 and CRP concentrations associated with hypoxia, exercise, and caloric deficit. Key Words: IL-6, TNF-!, C-REACTIVE 
PROTEIN, HYPOXIA, ENERGY DEFICIT 
A
thletes and military personnel who exercise or compromise physical work capacity (8,24). Therefore, 
work at high altitude experience hypoxia and, very preventing or attenuating the cytokine rise and the acute 
often, caloric deficit. Evidence indicates that the phase response may be beneficial during prolonged or 
stressors (i.e., hypoxia, exercise, caloric deficit) may intense physical work at high altitude. 
initiate an acute phase response (2,8,9,11,13,24), charac- Antioxidant supplementation has been shown to reduce 
terized by alterations in immune and inflammatory the plasma cytokine response to exercise at sea level 
responses (11,13,21), including increases in plasma inter- (23,27). Vassilakopoulos et al. (27) showed that an 
leukin-6 (IL-6), tumor necrosis factor-! (TNF-!), and antioxidant cocktail blunted the plasma IL-6 and TNF-! 
C-reactive protein (CRP) concentrations. Elevations in responses to 45 min of exercise in untrained individuals, 
plasma IL-6, TNF-!, and CRP concentrations may con- whereas Phillips et al. (23) demonstrated that supplemen­
tribute to altitude-associated illnesses (e.g., acute mountain tation reduced plasma IL-6 and CRP after eccentric 
sickness and high altitude pulmonary edema), which can exercise. In theory, antioxidant supplementation may 
counter the rise in free radical production, measured by 
markers of oxidative stress, which underlies the acute 
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that the exercise-induced cytokine increase is a reactive 
oxygen species (ROS)–dependent pathway. In contrast, 
others have shown that the exercise-induced plasma 
cytokine increase is not attenuated with antioxidant 
supplementation (17,21) and is not induced by oxygen free 
radicals (21). Because the oxidative stress response is 
sensitive to various exercise parameters, differences in the 
mode, duration, and intensity of exercise could explain 
previous contradictory findings. At high altitude, few 
studies (11,13) have evaluated the plasma cytokine and 
CRP responses to a controlled exercise bout and none have 
tried to attenuate these responses with antioxidant supple­
mentation. 
Therefore, the primary purpose of this investigation was 
to evaluate the efficacy of an antioxidant supplement in 
reducing plasma cytokine and CRP concentrations associ­
ated with the common conditions that occur at high altitude 
(i.e., hypoxia, exercise, caloric deficit). To mimic the daily 
total caloric deficit that is typically observed in individuals 
living and working at high altitude, a lower energy intake 
and higher energy expenditure were imposed. We hypoth­
esized that (a) resting plasma IL-6, TNF-!, and CRP 
concentrations would be elevated throughout the 14-d stay 
at high altitude, (b) plasma IL-6, TNF-!, and CRP 
concentrations would increase during and after prolonged 
submaximal exercise at high altitude compared with sea 
level, and (c) antioxidant supplementation would attenuate 
the rise in plasma IL-6, TNF-!, and CRP concentrations 
associated with hypoxia, exercise, and caloric deficit. 
METHODS 
Approach. A prospective, double-blind, placebo-
controlled design was used to determine the efficacy of 
antioxidant supplementation in reducing plasma cytokines 
and CRP concentrations in response to the common con­
ditions that can occur at high altitude (i.e., hypoxia, exer­
cise, caloric deficit). Testing phases included 5 d at  sea  
level and 14 d at high altitude, with subjects ingesting an 
antioxidant supplement or placebo during the high altitude 
phase. The main outcome variables were plasma cytokines 
(IL-6 and TNF-!) and CRP concentrations. Details of the 
study are outlined below. 
Study design. Subjects were first studied at sea level 
(Palo Alto, CA, 15-m elevation, atmospheric pressure 
748–762 torr) during a 7-d diet stabilization period, 
followed by a 5-d testing period during which they resided 
in the Clinical Studies Unit at the Veterans Affairs Palo 
Alto Health Care System (VAPAHCS). At sea level, 
energy expenditure was controlled and subjects were fed 
a weight-stabilizing diet. Cytokine and CRP concentrations 
were measured at rest and in response to exercise at sea 
level day 1 (SL). At 3 wk before departure for high 
altitude, subjects began taking an antioxidant or placebo 
supplement twice a day and continued throughout their 
2 wk stay at high altitude. Approximately 6 wk after the sea-
level phase, subjects were flown to Colorado Springs, CO 
(1850 m), where they spent the night in an apartment while 
breathing supplemental oxygen to maintain sea-level oxy­
gen saturation (Q97%). The next morning, subjects were 
driven to the summit of Pikes Peak, CO (4300 m, 
atmospheric pressure 458–464 torr) to the U.S. Army 
Research Institute of Environmental Medicine (USARIEM) 
facilities, while still breathing supplemental oxygen. Cyto­
kine and CRP testing was repeated before and after exercise 
on high altitude day 1 (HA1) and day 13 (HA13), and fasting 
CRP was measured on days 3 (HA3), 5 (HA5), and 10 
(HA10). While living at high altitude, energy intake and 
energy expenditure was altered to cause a 30–40% energy 
deficit (see below for details). The subjects resided on Pikes 
Peak in the USARIEM laboratory facility for the entire 14-d 
study. Figure 1 illustrates a timeline of the activities at sea 
level and high altitude. 
Subjects. A total of 18 healthy men (mean TSD; 25.1 T 
4.9 yr, 77.7 T 8.2 kg, 178.1 T 4.2 cm) were recruited to 
participate in the study from Stanford University and the 
surrounding areas (Palo Alto or San Jose, CA) using flyers 
and local newspaper advertisements. To participate in the 
current investigation, potential volunteers had to be partic­
j1ipating in 96 hIwk of regular endurance exercise, have a 
FIGURE 1—Timeline of activities at sea level (A) and 
high altitude (B). SL, sea level; HA, high altitude; Ex, 
exercise. 
peak oxygen uptake (V˙ O2peak) Q45 mLIkg
j1Iminj1, be  
able to complete a endurance cycle test for 1 h at 70–75% 
of energy output for peak oxygen consumption, have a 
body fat percentage between 5 and 16% measured by 
seven-site skinfold, and have no history of residence at 
altitudes 91500 m. All participants were in good overall 
health, nonsmokers, and disease free as determined by 
health history questionnaire and medical evaluation. Data 
of one individual were omitted because of a medical 
emergency unrelated to the study (final N = 17). Written 
informed consent was obtained from all individuals, and 
the institutional review boards at Stanford University and 
USARIEM approved the study. 
Screening tests. On admission to the Clinical Studies 
Unit at the VAPAHCS, a resting electrocardiogram (ECG), 
and a standard blood and urine chemistry panel was 
conducted. Following medical clearance, body composition 
was evaluated by seven-site skinfold test. Subjects then 
performed a continuous progressive exercise test to 
volitional exhaustion on a cycle ergometer (Sensormedics 
800, Yorba Linda, CA). An initial workload of 100 W was 
increased 30 W every 2 min until oxygen consumption 
failed to increase or the subject stopped, despite strong 
encouragement. During the test, expired air was analyzed 
using an online system (Parvomedics TrueMax 2400, 
Consentius Technologies, Sandy, UT), and V˙ O2peak was 
determined to be the highest 30-s value obtained. In addi­
tion, heart rate (Polar Electro Inc. A1, Woodbury, NY), 
rating of perceived exertion, and an ECG were continu­
ously monitored during the test. 
Antioxidant supplementation. Three weeks before 
going to high altitude, subjects were matched on age, body 
mass, V˙ O2peak, body fat percentage, partial pressure of end 
tidal volume CO2 (PETCO2), and hypoxic ventilatory 
response (HVR), and assigned to either an antioxidant 
supplement (AO; N = 9) or placebo (PL; N = 8) group in a 
double-blinded fashion (Table 1). The AO consisted of a 
capsule of ascorbic acid (250 mg), "-carotene (10,000 IU), 
!-tocopherol acetate (200 IU), selenium (50 2g), and zinc 
(15 mg), and the PL was an identical-looking and -tasting 
cellulose capsule. Subjects were instructed to ingest the 
supplement twice daily, once in the morning and once in 
the evening, continuing throughout the high-altitude phase. 
As reported previously by Subudhi et al. (26), the 
antioxidant protocol elevated blood concentrations in the 
AO group at high altitude compared with sea level for 
!-tocopherol (14.9 T 5.5, 10.0 T 3.8, respectively) and 
"-carotene (0.58 T 0.31, 0.26 T 0.17, respectively). The PL 
group had similar !-tocopherol and "-carotene concen­
trations to the AO group at sea level, with no subsequent 
change at high altitude. Based on previous research that 
has shown a reduction in cytokine concentrations and 
markers of oxidative stress in response to an antioxidant 
supplement (22,23,27), we formulated a broad-based 
antioxidant cocktail composed of vitamins and minerals 
to maximize the possible benefits of the supplement. 
Energy intake, energy expenditure and body 
composition. Subjects were fed a standardized diet 
TABLE 1. Physical characteristics of matched groups. 
Variable AO PL 
N 9 8 
Age (yr) 24.6 (5.5) 24.8 (4.0) 
Body mass (kg) 77.5 (7.8) 79.6 (8.7) 
Ht (cm) 180.6 (4.2) 176.8 (4.2) 
Body fat (%) 7.6 (2.9) 9.3 (3.8) 
V˙ O2peak (mLIkg
j1Iminj1) 
LIminj1 
57.0 (1.5) 
4.4 (0.6) 
53.9 (10.1) 
4.3 (0.8) 
PETCO2 (torr) 40.4 (1.7) 40.8 (2.4) 
HVR 0.9 (0.8) 1.0 (0.7) 
Values are mean (SD) for AO and PL. AO, antioxidant supplement group; PL, placebo 
group; V˙ O2peak, peak oxygen uptake; PETCO2, partial pressure of end-tidal carbon 
dioxide; HVR, hypoxic ventilatory response. 
throughout the study composed of whole foods (e.g., pasta, 
bagels, cereal) containing modest levels of antioxidants (just 
below the RDA). Energy intake was initially estimated 
before the first day of sea-level testing with the Harris– 
Benedict equation, using an activity factor between 1.5 and 
1.9, and, if necessary, was adjusted during the next 7 d to 
maintain body mass. After the weight-stabilization period, 
energy intake was maintained for the next 4 d with the diet 
composed of 63% carbohydrate, 23% fat, and 13% protein. 
Energy expenditure was estimated from self-reported daily 
activity logs in which the subjects recorded all activities for 
each 24-h period in 15-min intervals using the ACSM 
compendium of physical activities (1). On several occasions 
for each subject, heart rate was monitored to assess energy 
expenditure. While at sea level, subjects maintained their 
normal exercise routine. 
Military personnel exposed to field training exercises and 
prolonged excursions (including high altitude) typically 
experience a caloric deficit Q1000 kcalIdj1 mainly because 
of elevated energy expenditure (5). The goal of the high-
altitude phase of this study was to mimic the typical 
undernutrition observed during these field training exer­
cises and prolonged excursions at high altitude, therefore, 
subjects were asked to increase their energy expenditure to 
j11200–1500 kcalId more than at sea level (40% of caloric 
intake) while maintaining sea-level energy intake values. 
At high altitude, energy expenditure was estimated as 
described above. For all subjects, total daily energy 
expenditure was adjusted with basal metabolic rate 
(BMR), which was assessed by indirect calorimetry on 
high-altitude days 2 through 6 and days 10 through 13. To 
elevate energy expenditure, subjects had unlimited access to 
treadmills, cycle ergometers, and rowing and ski machines, 
and were required to participate on a hike for 1–3 h 
(93650 m of elevation) at least three times throughout the 
high-altitude phase. If subjects were unable to achieve their 
targeted energy expenditure each day at high altitude, 
energy intake was adjusted to reach a total energy deficit 
of approximately 1200–1500 kcalIdj1. Subjects were given 
continuous feedback on a daily basis to ensure that the 
overall caloric deficit at high altitude was approximately 
40% of their sea-level energy intake. 
Fasted body mass was measured every morning at SL and 
HA, and body fat percentage was evaluated at SL and at HA1, 
HA3, HA5, HA10, and HA14 using skinfold calipers. Fat-
free mass was calculated as body mass minus body fat mass. 
Prolonged submaximal exercise cycling test. 
Prolonged submaximal exercise cycling (SEC) tests were 
performed on SL day 1 (after 7 d of diet stabilization), and 
HA1 and HA13 on an electromagnetically braked cycle 
ergometer (Sensormedics). Exercise was prohibited 36 h 
before all trials, and energy intake was adjusted to account 
for the lower energy expenditure the day before the SEC 
test at HA. After a 12-h overnight fast, subjects consumed 
a standardized breakfast (478 kcal) composed of 74% 
carbohydrate, 14% fat, and 12% protein. Within 2 h after 
consumption of the meal, subjects were required to 
consume at least 250 mL of water. A catheter was then 
inserted into a forearm vein and a venous blood sample 
was taken at rest 2 h after eating. Subjects then rode the 
cycle ergometer at a pedal speed between 70 and 90 rpm. 
At sea level, subjects exercised at 55.0% T 4.1 of V˙ O2peak 
until approximately 1500 kcal was expended. At high 
altitude, subjects exercised at the same relative intensity as 
sea level (i.e., same percent of high altitude V˙ O2peak), and 
the same absolute workload on HA1 and HA13, again until 
an energy expenditure of approximately 1500 kcal was 
achieved. Previous research has shown that V˙ O2peak at 
4300 m is reduced by approximately 25% compared with 
sea level (6); therefore, the relative intensity level at high 
altitude was estimated using the sea-level V˙ O2peak values 
and the predicted decrement. The actual average reduction 
in V˙ O2peak determined on day 2 at HA was 27% (26), 
meaning that the actual relative intensity during the SEC 
test was 57.0% T 2.9 of V˙ O2peak. Because of this reduction 
during the SEC test, the absolute workload decreased 
compared with sea level and the duration of exercise at 
high altitude increased compared with sea level (193 T 25 
vs 135 T 25 min, respectively). Oxygen consumption was 
measured during the initial 5 min of rest and 15 min of 
exercise, and then the last 5 min of every hour completed 
to ensure the required exercise intensity was being 
maintained. During exercise the same volume of water 
was consumed during all tests. Heart rate and oxygen 
saturation were recorded every 15 min. After completion of 
exercise, subjects consumed a standardized lunch (738 kcal) 
composed of 53% carbohydrate, 17% fat, and 29% protein. 
Blood samples were collected at rest, at the end of 
exercise, and 2, 4, and 20 h after exercise. 
Resting C-reactive protein. Resting CRP was deter­
mined after a 10- to 12-h overnight fast at SL and HA3, 
TABLE 2. Body composition at sea level and high altitude. 
HA5, and HA10. Exercise was prohibited a minimum of 
14 h before obtaining the blood draw. 
Biochemical and acute mountain sickness 
analyses. Blood samples were collected in sterile syrin­
ges and transferred to EDTA tubes, then immediately spun 
in a refrigerated centrifuge (3,000 � g) for 15 min. The 
plasma was aliquotated into polystyrene tubes and stored at 
j80-C until analyzed. Plasma concentrations of IL-6 and 
TNF-! were determined by high-sensitivity enzyme-linked 
immunosorbent assay (ELISA) kits using 96-well plates 
(R&D Systems, Minneapolis, MN), and plasma CRP 
concentrations were analyzed by the Palo Alto VA 
Laboratory using a high-sensitivity assay. Catecholamine 
concentrations were determined by high-performance 
liquid chromatography (HPLC; BioRad Model 1330 pump, 
Model 1340 electrochemical detector) with electrochemi­
cal detection as previously described (14). Acute mountain 
sickness scores (AMS), assessed by Lake Louise and 
Environmental Symptoms questionnaires (ESQ), were 
determined at SL and throughout the HA stay (data 
published elsewhere). In the present investigation, AMS 
scores were used for correlations with plasma cytokine and 
CRP concentrations. 
Statistical analysis. Data were analyzed using SAS 
Inc. software (Cary, NC). A mixed model three-way 
ANOVA with one between factor (group) and two within 
factors (day and time) was used to determine the group � 
day � time interaction using a compound symmetric 
covariate structure. Pearson product moment correlations 
were used to assess the relationship of plasma cat­
echolamines with plasma IL-6 or CRP concentrations, 
and AMS with plasma IL-6 and CRP concentrations. When 
appropriate, post hoc tests of significance were performed 
with a Tukey HSD test. By convention, the a priori level of 
significance was set at ! G 0.05. 
RESULTS 
Energy intake, energy expenditure, and body 
composition. By design, energy intake and energy 
expenditure were equivalent at SL (mean TSD; 3895 T 
j1 j1348 kcalId and 4078 T 531 kcalId , respectively). At 
HA, the planned dietary restriction and increased physical 
activity resulted in a decreased energy intake and increased 
j1energy expenditure of 3357 T 579 kcalId and 4723 T 
SL HA Day 1 HA Day 3 HA Day 5 HA Day 10 HA Day 14 
Body mass (kg) 
AO 
PL 
Fat mass (kg) 
77.5 (7.8) 
79.6 (8.7) 
77.5 (7.7) 
80.3 (8.9) 
77.0 (7.6) 
80.3 (9.0) 
76.1 (7.6)*y
79.1 (8.7)*y 
75.2 (7.5)*y
78.0 (9.1)*y 
73.9 (7.5)*y
76.5 (8.8)*y 
AO 6.0 (2.5) 6.2 (2.6) 6.2 (2.8) 5.9 (2.3) 5.3 (2.3)* 5.0 (2.3)* 
PL 7.6 (3.7) 8.0 (3.8) 7.4 (5.4) 8.1 (4.6) 7.5 (3.8) 7.1 (4.3)* 
Fat-free mass (kg) 
AO 
PL 
71.6 (7.3) 
72.0 (6.8) 
71.2 (7.3) 
72.9 (7.4) 
70.2 (7.4) 
72.2 (7.1) 
69.9 (7.5)*y
70.6 (6.5)*y 
69.0 (7.6)*y
69.5 (7.6)*y 
68.6 (7.5)* 
69.2 (7.2)* 
Values are mean (SD) for AO and PL. * Significantly different than SL and HA day 1 (P G 0.05). ySignificantly different than previous measurement (P G 0.05). AO, antioxidant 
supplement group; PL, placebo group; SL, sea level; HA, high altitude. 
FIGURE 2—Plasma IL-6 concentrations at rest, at the end of exercise 
(Ex), and after exercise (2, 4, and 20 h) for AO (A) and PL (B) groups. 
Values are mean (SEM). * Significantly different than rest for SL, HA 
day 1, and HA day 13 (P G 0.001); y HA day 1 significantly different 
than SL and HA day 13 (P = 0.035). AO, antioxidant supplement 
group; PL, placebo group; IL-6, interleukin-6; SL, sea level; HA, high 
altitude; Ex, end of exercise. 
j1484 kcalId , respectively, for a total energy deficit of 
j11385 T 531 kcalId . The total energy deficit for the AO 
and PL groups was similar at HA (1400 T 465 kcalIdj1 and 
j11331 T 613 kcalId , respectively). The resulting changes 
in body mass, fat-free mass, and fat mass were similar 
between the groups (Table 2). Body mass and fat-free mass 
were reduced approximately 4.3 and 3.1 kg throughout the 
duration of high altitude, respectively. Fat mass was 
significantly reduced in both groups by HA day 14 
compared with sea level. Body composition changes over 
the course of the study are presented in Table 2. 
Prolonged submaximal exercise cycling test. No 
difference was seen in steady-state V˙ O2 during exercise 
between the AO and PL groups at SL (31.4 T 0.8 vs 29.7 T 
5.6 mLIkgj1Iminj1, respectively), HA1 (21.9 T 0.8 vs 
FIGURE 3—Plasma CRP concentrations at rest, at the end of exercise 
(Ex), and after exercise (2, 4, and 20 h) for AO (A) and PL (B) groups. 
Values are mean (SEM). * Significantly different than rest (P G 0.001) 
for HA day 1; y HA day 1 significantly different than SL and HA day 
13 (P G 0.001). AO, antioxidant supplement group; PL, placebo group; 
CRP, C-reactive protein; SL, sea-level; HA, high altitude; Ex, end of 
exercise. 
20.6 T 3.9 mLIkgj1Iminj1, respectively), or HA13 (21.9 T 
0.8 vs 20.4 T 4.3 mLIkgj1Iminj1, respectively), and the total 
volume of O2 consumed for the SEC test (317 T 173 L) was 
similar for each group. No difference was noted in oxygen 
saturation during exercise between groups. Within the AO 
and PL groups, oxygen saturation was significantly lower at 
HA1 (72 T 8 and  75  T 5, respectively) compared with SL 
(96 T 1 and  97  T 1, respectively) and HA13 (82 T 3 and  83  T 
4, respectively). Heart rate was not different between groups. 
Heart rate was significantly lower for AO and PL at HA13 
(115 T 11 and 119 T 10 bpm, respectively) compared with SL 
(129 T 7 and 138 T 12 bpm, respectively) and HA1 (129 T 11 
and 124 T 20 bpm, respectively). 
Plasma cytokines, C-reactive protein, and cate­
cholamine concentrations. No group differences were 
found between AO and PL in plasma IL-6, CRP, TNF-!, 
or catecholamine concentrations. For both groups, plasma 
IL-6 concentration was significantly higher at the end of 
exercise, 2, 4, and 20 h after exercise at HA1 compared 
with SL and HA13 (Fig. 2), with the maximal value for 
both groups on HA1 approximately 100% greater com­
pared with SL and HA13. At HA1, plasma IL-6 increased 
approximately 42 times compared with rest for both groups 
j1with peak values of 17.1 T 3.8 and 18.2 T 5.5 pgImL for 
AO and PL, respectively. Plasma catecholamine con­
centrations and AMS scores were not correlated with 
IL-6 (P 9 0.05). For both groups, plasma CRP con­
centrations were significantly elevated 20 h after exercise 
at HA1 compared with SL and HA13 (Fig. 3). The 
maximal rise for both groups at HA1 was approximately 
200% greater compared with SL and HA13. At HA1, 
plasma CRP concentration increased approximately sixfold 
compared with rest for both groups with peak values of 
j12.1 T 0.8 and 2.4 T 0.7 mgIL for AO and PL, 
respectively. Plasma norepinephrine was significantly 
correlated with CRP on HA1 at 20 h after exercise 
(Fig. 4; combined data, r2 = 0.42, P = 0.005); however, 
FIGURE 4—Relationship between 20 h after exercise plasma CRP 
and plasma norepinephrine (data combined; P = 0.005, r2 = 0.42). 
CRP, C-reactive protein. 
TABLE 3. Plasma TNF-! (pgImLj1) response to the prolonged submaximal exercise 
test for both groups. 
End of 2 h After 4 h After
 
Group Test Day Rest Exercise Exercise Exercise
 
AO	 SL 2.1 (1.2) 1.8 (1.1) 1.7 (1.1) 1.7 (0.9) 
HA day 1 1.9 (0.8) 1.7 (1.1) 1.6 (1.0) 1.7 (0.8) 
HA day 13 1.6 (0.4) 1.7 (1.2) 1.9 (1.4) 1.8 (1.2) 
PL SL 1.8 (0.8) 1.7 (0.4) 1.6 (0.8) 1.7 (0.6) 
HA day 1 2.0 (0.8) 2.1 (1.1) 1.8 (1.0) 1.8 (0.9) 
HA day 13 1.9 (0.8) 1.7 (0.6) 1.5 (0.9) 1.3 (0.7) 
Values are mean (SD) for AO and PL. AO, antioxidant supplement group; PL, placebo 
group; TNF-!, tumor necrosis factor !; SL, sea level; HA, high altitude. 
plasma epinephrine and AMS scores were not (P 9 0.05). 
Plasma TNF-! concentration did not differ between any 
conditions (Table 3). For both groups (data combined), 
plasma epinephrine concentrations were significantly ele­
vated at the end of exercise, 2, 4, and 20 h after exercise on 
HA1 compared with sea level and HA13 (Fig. 6). Plasma 
norepinephrine concentrations (data combined) tended to 
be higher at HA1 and HA13 compared with SL, but did not 
reach statistical significance (Fig. 6). 
Resting C-reactive protein. No difference was seen 
in resting plasma CRP concentration between the groups 
(Fig. 5). Plasma CRP concentration was significantly 
elevated at HA3 and HA5 compared with SL for both 
groups, but returned to similar SL values at HA10. Plasma 
CRP concentration tended to be higher for the AO group at 
HA10 compared with the PL group because one subject_s 
CRP value was approximately 560% greater than the group 
j1 mean (10.1 vs 1.6 mgIL , respectively). No significant 
correlations were found between plasma norepinephrine or 
epinephrine and resting CRP (P 9 0.05). Because CRP 
concentrations initially rose over time at high altitude (days 
3 and 5), it is possible that the elevation of plasma CRP 
FIGURE 5—Resting plasma CRP concentrations at SL and HA days 
3, 5, and 10. Values are mean (SEM). y HA day 3 and HA day 5 
significantly different than SL for both groups (P = 0.028). AO, 
antioxidant supplement group; PL, placebo group; CRP, C-reactive 
protein; SL, sea level; HA, high altitude. 
FIGURE 6—Plasma epinephrine (A) and norepinephrine (B) concen­
trations at rest, at the end of exercise (Ex), and after exercise (2, 4, 
and 20 h) for AO and PL groups (data combined). Values are 
mean (SEM). * HA day 1 significantly different than SL and HA day 
13 (P G 0.001). AO, antioxidant supplement group; PL, placebo group, 
HA, high altitude; SL, sea level. 
concentrations on HA1 at 20 h after exercise is a factor of 
the duration of altitude exposure rather than the SEC test, 
per se. 
DISCUSSION 
Military personnel or athletes working at high altitude 
may experience several stressors (e.g., hypoxia, exercise, 
energy deficit) that will initiate an acute phase response 
and contribute to altitude-associated illness (8,9,11,13), 
which may be detrimental to work capacity or performance 
over time. In the present investigation, we evaluated the 
efficacy of an antioxidant supplement in reducing the acute 
phase response associated with hypoxia, exercise, and 
caloric deficit at high-altitude exposure (4300-m elevation) 
by measuring changes in cytokines and CRP responses in 
subjects given a placebo or antioxidant supplement. We 
found that plasma IL-6 and CRP concentrations were 
elevated in response to exercise during acute high-altitude 
exposure compared with sea level, although plasma TNF-! 
concentrations were not elevated. The elevation in plasma 
IL-6 and CRP concentrations in response to exercise, how­
ever, did not persist at high altitude. In addition, resting 
plasma CRP returned to similar sea-level values during the 
14-d stay at high altitude. Finally, in contrast to our 
primary hypothesis, antioxidant supplementation did not 
attenuate the rise in plasma IL-6 and CRP concentrations 
associated with hypoxia, exercise, and caloric deficit. 
Antioxidant supplementation. Antioxidant supple­
mentation in this investigation did not attenuate the rise in 
plasma IL-6 or CRP concentrations, which is in agreement 
with some studies performed at sea level and high altitude 
(2,17,21), but not others (23,27). A few explanations for 
the lack of effect of antioxidant supplementation in our 
data may exist. First, it has been hypothesized that an 
antioxidant supplement blunts the cytokine response 
through a ROS-dependent pathway as an increase in 
oxidative stress markers have been associated with elevat­
ed production of cytokines (27). We, however, previously 
reported that prolonged submaximal exercise at high 
altitude did not induce any significant increases in oxida­
tive stress markers (i.e., lipid hydroperoxides, reduced 
glutathione, oxidized glutathione, and glutathione peroxi­
dase) (26), even in the placebo group. The lack of ROS 
response suggests that either no additional ROS were 
generated or the endogenous production of antioxidants 
was sufficient at matching the generation of ROS. Because 
we saw an increase in cytokines without an elevation in 
ROS, the contribution of ROS to cytokine production in 
response to prolonged, submaximal exercise at high altitude 
may be minimal, with other factors (e.g., skeletal muscle 
contraction, depleted skeletal muscle glycogen stores, 
increased sympathetic activity) possibly playing a more 
significant role in elevating plasma cytokines. This would 
minimize the effects of antioxidant supplementation on 
cytokine production. Bailey et al. (2) also found a dis­
association between markers of oxidative stress and plasma 
cytokines in volunteers ascending to 4780 m. Although we 
saw an elevation in plasma catecholamine concentrations 
at the end of exercise (+20%), we must note that the inten­
sity of the SEC test (approximately 55% V˙ O2peak) may not 
have been sufficiently strenuous to generate any ROS 
production, diminishing the effects of the antioxidant 
supplement. We chose the same relative exercise intensity 
at sea level and high altitude instead of the same absolute 
exercise intensity because, based on previous unpublished 
observations, the relative exercise intensity of approxi­
mately 55% of V˙ O2peak was considered an upper limit for 
prolonged, steady state exercise at acute high-altitude 
exposure. Together, these contradictory studies suggest 
that the contribution of ROS to cytokine production re­
mains to be determined both at sea level and high altitude. 
Second, previous reports have shown a reduction in 
plasma cytokines with antioxidant supplementation in 
untrained, but not trained individuals (17,21,23,27). 
Indeed, resting antioxidant levels in endurance-trained 
individuals have been shown to be higher than in sedentary 
individuals (4), and antioxidant concentrations may stay 
elevated during and after an exercise bout in trained 
individuals (21). Therefore, the recreationally trained 
subjects in this investigation may have had a natural 
antioxidant defense system that was not further enhanced 
by supplementation. Direct comparison between trained 
and untrained individuals is difficult to interpret, however, 
because exercise duration and intensity have been different 
(17,27). To clarify this issue, future studies should directly 
compare the impact of antioxidant supplementation on 
cytokine production in trained and untrained subjects 
exercising at the same exercise intensity and duration. 
Finally, research has shown that plasma cytokine 
concentrations are correlated with levels of plasma cat­
echolamines. More specifically, IL-6 responses at rest and 
during exercise are dependent on a strong "-adrenergic 
component, and a "-adrenergic antagonist blocks the IL-6 
response (19). Exercise combined with hypoxia further 
increases the epinephrine response (15), which may 
enhance the cytokine response at altitude. In this investi­
gation, antioxidant supplementation may not have attenu­
ated the rise in IL-6 and CRP because a strong adrenal 
release of epinephrine in response to hypoxia may have 
overridden the efficacy of the antioxidant supplement. In 
contrast, Lundby et al. (11) found that the catecholamine 
response to exercise at altitude did not significantly 
contribute to elevated plasma IL-6 levels. In this investi­
gation, plasma catecholamine concentrations were not 
correlated with plasma cytokines. In summary, the results 
of this investigation are not consistent with the hypothesis 
that antioxidant supplementation attenuates the cytokine 
and CRP response associated with high-altitude exposure, 
prolonged submaximal exercise, and caloric deficit in 
recreationally trained subjects. 
Cytokine response. Previous research at high altitude 
has shown that plasma IL-6 concentrations are elevated 
during exercise at the same absolute (same work rate), but 
not relative (same percentage of maximal work rate) 
exercise intensity compared with sea level (11,13). We, 
however, did show a twofold increase in plasma IL-6 
on acute altitude exposure compared with sea level during 
and after exercise at the same relative workload (~55% 
of V˙ O2peak) (Fig. 2). It may be that the increased dura­
tion of exercise in our study at high altitude (resulting 
in the same total energy flux) was sufficient to induce 
a greater response in plasma IL-6 despite the similar 
relative workloads. Indeed, a study by Lundby et al. (11) 
demonstrated, with similarly recreationally trained 
subjects working at a comparable work load as in our 
study, a peak exercise and altitude-induced increase in 
j1plasma IL-6 of only about 6 pgImL after 1 h of exercise 
compared with our observed increase of approximately 
j118 pgImL after 3 h, suggesting that duration of exercise 
may be important. 
In contrast to the HA1 response, we did not show an 
increase in plasma IL-6 concentrations in response to 
exercise at HA13 compared with sea level (Fig. 2), which 
is in disagreement with others (11,13). Because the 
subjects in this investigation exercised a minimum of 
j14 hId for the entire duration at high altitude (~20% 
increase above sea-level energy expenditure), they may 
have adapted to the elevated energy expenditure, thereby 
blunting the plasma IL-6 response during the 3-h exercise 
test at HA13. Subjects completed the prolonged exercise 
test more easily and expressed feelings of less weakness 
and fatigue at HA13 compared with HA1, despite no 
accompanying increase in V˙ O2peak over the 14-d stay at 
altitude (subjects were still working at the same relative 
intensity). In addition, subjects displayed higher oxygen 
saturation during the SEC test at HA13 compared with 
HA1 (83 vs 73%, respectively; P G 0.05), suggesting that 
acclimatization had occurred during the 14-d stay at high 
altitude. In summary, our results suggest that acclimatiza­
tion over a 14-d stay at high altitude, combined with 
elevated energy expenditure, attenuates the rise in plasma 
IL-6 concentrations in response to exercise initially observed 
on HA1. 
To our knowledge, this is the first investigation to 
evaluate the plasma TNF-! response to a controlled bout of 
exercise at high altitude. Because TNF-! is elevated after a 
prolonged and intense exercise bout (e.g., marathon race) 
at sea level (18), we predicted TNF-! would be elevated 
after exercise at high altitude. In contrast to our hypothesis, 
plasma TNF-! did not differ at either sea level or high 
altitude. Both animal and human studies suggest that 
circulating levels of IL-6 inhibit TNF-! production. 
Mizuhara et al. (16) demonstrated that rIL-6 administration 
in mice reduces TNF-! production by 40–50%. In humans, 
Starkie et al. (25) demonstrated that both exercise and 
infusion of rhIL-6 blunts circulating plasma levels of 
TNF-!. In addition, Pedersen et al. (20) proposed that 
exercise-induced elevations in TNF-! are caused by 
endotoxemia only after extreme exercise (e.g., marathon 
race), but other modes of aerobic exercise do not elevate 
plasma TNF-!. Evidence seems to support this theory as 
most, but not all, have shown increases after a marathon 
race, but not more modest exercise (7,18). The lack of 
change in plasma TNF-! concentration in this investigation 
at both sea level and high altitude supports the theory that 
prolonged cycle ergometer exercise is not a sufficient 
stressor to elevate plasma TNF-!. 
C-reactive protein response. Plasma concentration 
of CRP, an acute-phase protein largely regulated by IL-6, 
is augmented after exercise at sea level (3). Most studies at 
high altitude have focused on the CRP response to acute 
hypoxia (8) and not the combined effects of strenuous 
exercise and hypoxia. We found that the plasma CRP 
response after exercise at HA1 was elevated compared with 
SL and HA13. It is possible that this elevation is related 
to the increased plasma IL-6 response and heightened 
sympathetic activity (Figs. 3 and 4). Research has 
consistently shown that a rise in plasma IL-6 induces an 
elevation in the hepatic-derived CRP 3–20 h after exercise 
(24). Furthermore, the significant correlation in this 
investigation between plasma norepinephrine and CRP 
concentrations (Fig. 3) on HA1 at 20 h after exercise 
suggests a potential link between increased sympathetic 
activity and a rise in plasma CRP at high altitude. Plasma 
norepinephrine is a good marker of increased sympathetic 
activity (14,15), which can remain elevated for up to 14 d 
of high-altitude exposure (15). We also saw elevated 
resting norepinephrine concentrations throughout the 14-d 
stay at high altitude, but no correlation was found between 
plasma norepinephrine and plasma CRP concentrations 
during the latter days of altitude exposure. 
High-volume exercise training, with insufficient rest, will 
initiate an acute phase response and is thought to continu­
ously increase resting CRP levels (24); however, research 
supporting this theory is minimal. In this investigation, the 
resting plasma CRP response was augmented at high 
altitude (Fig. 5). Subjects were asked to increase their 
j1energy expenditure by approximately 1200–1500 kcalId
at high altitude, but we were only partially successful 
because energy expenditure increased approximately 750 
j1kcalId and energy intake decreased approximately 
j1550 kcalId , resulting in an approximately 4.3-kg loss of 
body mass over a 2-wk period. Nonetheless, the resting 
plasma CRP response at HA10 (Fig. 5) and HA14 (Fig. 2) 
returning to similar sea-level values was surprising and 
contradicted our hypothesis. Our results are consistent 
with research at sea level, which has shown that after 
a period of increased training intensity and volume, 
plasma CRP was either reduced or returned to baseline 
values (12). 
Methodological consideration. In the current inves­
tigation, because we altered energy intake and expenditure 
to induce a total energy deficit of approximately 1500 
j1kcalId at high altitude and not at sea level, it is difficult 
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